文献速递类风湿关节炎

评估脂多糖在关节中的作用:纤连蛋白作为一种新型保护机制

Evaluating the role of lipopolysaccharides in the joint: fibronectin as a novel protective mechanism.
PubMed 文献 · RMD Open · 2025-07-10

研究检测56例骨关节炎、7例类风湿关节炎和39例创伤患者滑液中脂多糖的浓度与生物活性,并在大鼠模型及体外实验中观察其致炎作用与纤连蛋白的相互作用。结果显示各组滑液均检出脂多糖且浓度与脂质A谱相近,但生物活性低,长期全身给予脂多糖未诱导大鼠关节骨关节炎样改变,纤连蛋白结合可减弱脂多糖生物活性。

要点

  • 骨关节炎、类风湿关节炎与创伤患者滑液均检出脂多糖,各组浓度与脂质A谱相近
  • 滑液脂多糖生物活性低,提示存在内源性中和因子,脂多糖非关节炎症主要驱动因素
  • 纤连蛋白与脂多糖在滑膜共定位,结合后减弱其生物活性并阻碍其迁移

核心结论

  • 脂多糖在多种关节疾病滑液中普遍存在但生物活性低,不是关节炎症的主要驱动因素。
  • 纤连蛋白在滑膜环境中隔离并中和脂多糖,提供对抗脂多糖诱导炎症的保护机制。
  • 上述发现强调需要准确的脂多糖检测技术,并提示调节关节炎症的潜在治疗靶点。

研究设计与样本

  • 分析56例骨关节炎、7例类风湿关节炎和39例创伤患者的滑液样本,检测脂多糖浓度与生物活性,并用液相色谱-质谱联用(LC-MS)评估脂质A组成。
  • 大鼠模型中全身给予脂多糖32天以评估其对关节退变的影响。
  • 通过体外实验和三维滑膜膜模型检查脂多糖与滑膜蛋白尤其纤连蛋白(Fn)的相互作用。

主要发现

  • 所有滑液样本均检出脂多糖,各组间浓度和脂质A谱相近。
  • LC-MS测得的脂多糖水平高于标准内毒素检测法所得结果,提示传统检测方法存在局限。
  • 尽管脂多糖存在升高,生物活性检测显示促炎反应极小,提示滑液内存在中和脂多糖的固有因子。
  • 体内实验中,长期全身脂多糖暴露未诱导大鼠关节出现骨关节炎样改变。
  • 脂多糖与纤连蛋白在滑膜共定位,纤连蛋白结合减弱脂多糖生物活性并在体外阻碍其迁移。

临床怎么用

  • 作者认为这些发现强调需要准确的脂多糖测量技术。
  • 作者认为这些发现提示调节关节炎症的潜在治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the presence and bioactivity of lipopolysaccharides (LPS) in synovial fluid (SF) of osteoarthritis (OA) patients and elucidate mechanisms modulating their inflammatory potential. METHODS: SF samples from 56 OA, 7 rheumatoid arthritis and 39 trauma patients were analysed for LPS concentration and bioactivity. Lipid A composition was assessed using liquid chromatography-mass spectrometry (LC-MS). In a rat model, LPS was administered systemically for 32 days to evaluate its impact on joint degeneration. The interaction between LPS and synovial proteins, particularly fibronectin (Fn), was examined through in vitro assays and a 3D synovial membrane model. RESULTS: LPS was detected in all SF samples with comparable concentrations and lipid A profiles across all groups. LC-MS measurements indicated higher LPS levels than those obtained from standard endotoxin assays, suggesting limitations in conventional detection methods. Despite elevated LPS presence, bioactivity assays revealed minimal proinflammatory responses, implying the existence of intrinsic SF factors neutralising LPS. In vivo, prolonged systemic LPS exposure did not induce OA-like changes in rat joints. Notably, LPS colocalised with Fn in the synovial membrane, and Fn binding attenuated LPS bioactivity and hindered its migration in vitro. CONCLUSIONS: LPS is prevalent in SF across various joint conditions but exhibits low bioactivity, indicating it is not a primary driver of joint inflammation. Fn plays a crucial role in sequestering and neutralising LPS within the synovial environment, offering a protective mechanism against LPS-induced inflammation. These findings underscore the need for accurate LPS measurement techniques and suggest potential therapeutic targets for modulating joint inflammation.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Bevc K, Zhang S, Pazos-Perez A, et al. Evaluating the role of lipopolysaccharides in the joint: fibronectin as a novel protective mechanism. RMD Open. 2025. PMID: 40645615. doi:10.1136/rmdopen-2025-005622

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。